A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management

Autor: Pi-Sunyer, Xavier, Astrup, Arne, Fujioka, Ken, Greenway, Frank, Halpern, Alfredo, Krempf, Michel, Lau, David C. W., le Roux, Carel W., Ortiz, Violante, Jensen, Christine Bjorn, Wilding, John P. H., Hamann, A, Barakat, A, Blüher, M, Linn, T, DALLE MOLLE, Alberto, Segner, A, Stübler, P, Tosch-Sisting, R, Pacini, F, Santini, F, Marchesini, G, Rotella, Cm, Invitti, C, Vettor, R, Buscemi, S, Raya, Pm, Freijoo, Fc, de Barbará RG, Carraro, R, Bobillo, Er, de la Cuesta, C, Farsang, C, Csaszar, A, Zahorska-Markiewicz, B, Pupek-Musialik, D, Franek, E, Ostrowska, L, Olszanecka-Glinianowicz, M, Lalic, N, Micic, D, Ludvik, B, Paulweber, B, Prager, R, Scheen, A, Van Gaal, L, Astrup, Av, Hermansen, K, Madsbad, S, Rissanen, A, Nieminen, S, Savolainen, M, Krempf, M, Romon, M, Laville, M, Marre, M, Mira, R, Finucane, F, Veenendaal, A, van Berkum, F, Johannsson-Vidarsdóttir, S, Van de Walle, V, Meesters, E, Hjelmesæth, J, Klemsdal, To, Kulseng, B, Bach-Kliegel, B, Laederach, K, Villiger, L, Golay, A, Bilz, S, Sathyapalan, T, Bain, S, Kumar, S, Le Roux CW, Lean, Me, Mcgowan, B, Rehman, T, Wilding, J, Wittert, G, Caterson, I, Proietto, J, Prins, J, Geloneze Neto, B, Gross, Jl, Chacra, Ar, Halpern, A, Suplicy Hde, A, Chow, Fc, Thacker, Hp, Chadha, M, Chandalia, H, Unnikrishnan, A, Kalra, S, Deshpande, N, Shunmugavelu, M, Deshmukh, Vc, Maislos, M, Lieberman, Gs, Shimon, I, Stern, N, Nabriski, D, Karnieli, E, Shehadeh, N, Gonzalez-Galvez, G, Arechavaleta-Granell Mdel, R, Violante Ortiz RM, Franco, Gm, Gurieva, I, Suplotova, La, Troshina, E, Ruyatkina, La, Voychik, Ea, Martsevich, S, Startseva, Ma, Seeber, Me, Badat, A, Ellis, G, Altuntas, Y, Guler, S, Ulgen, E, Delibasi, T, Chetty, T, Hart, R, Janzen, J, Labonte, I, Lau, D, Liutkus, J, O'Keefe, D, Padwal, R, Ransom, Tp, Tytus, R, Weisnagel, Sj, Adler, J, Aqua, K, Aronoff, Sl, Bedel, Gw, Blevins, Tc, Blumenau, J, Brockmyre, Ap, Call, Rs, Canadas, R, Chaykin, Lb, Cohen, K, Conrow, Jk, Davis, Mg, Downey, Hj, Drosman, Sr, Duckor, S, Farmer, H, Farrell, J, Fehnel, S, Finneran, Mp, Forbes, R, Forker, A, Fredrick, M, Fujioka, K, Geller, Sa, Gill, S, Glaser, L, Greco, Sn, Greenway, Fl, Harper, W, Herman, L, Hoekstra, J, Ingebretsen, R, Ison, R, Jain, Rk, Kaplan, R, Kaster, Sr, Haase, Ga, Kerzner, B, Kirstein, Jl, Koltun, W, Krieger, Dr, Lewis, Ce, Madder, R, Marple, Rn, Mcdermott, Ej, Mello, Cj, Miller, Ab, Mullen, J, Nardandrea, J, O'Neil, P, Pi-Sunyer, F, Pucillo, Rm, Rhee, C, Redrick, S, Pardini, A, Rothman, J, Rubino, Dm, Sellers, G, Smith, T, Byars, Wd, Soufer, J, Sussman, Am, Patrick, K, Schramm, El, Van Cleeff, M, Berg, Sr, Wyatt, Hr, Simon, Ja.

Publikováno v: New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2015, 373 (1), pp.11-22. ⟨10.1056/NEJMoa1411892⟩

BACKGROUND: Obesity is a chronic disease with serious health consequences, but weight loss is difficult to maintain through lifestyle intervention alone. Liraglutide, a glucagon-like peptide-1 analogue, has been shown to have potential benefit for we

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5e40d98dbc827ba4298e71fbd08a8ac
https://pubmed.ncbi.nlm.nih.gov/26642873

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Preoperative Identification of Medullary Thyroid Carcinoma (MTC): Clinical Validation of the Afirma MTC RNA-Sequencing Classifier.

Autor: Randolph GW; Division of Thyroid and Parathyroid Endocrine Surgery, Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, USA.; Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Sosa JA; Department of Surgery, University of California San Francisco (UCSF), San Francisco, California, USA., Hao Y; Department of Research and Development, Veracyte, Inc., South San Francisco, California, USA., Angell TE; Division of Endocrinology and Diabetes, Keck School of Medicine, University of Southern California, Los Angeles, California, USA., Shonka DC , Jr; Department of Otolaryngology-Head and Neck Surgery, University of Virginia, Charlottesville, Virginia, USA., LiVolsi VA; Anatomic Pathology Division, Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA., Ladenson PW; Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA., Blevins TC; Texas Diabetes and Endocrinology, Austin, Texas, USA., Duh QY; Section of Endocrine Surgery, Department of Surgery, University of California San Francisco, San Francisco, California, USA., Ghossein R; Department of Pathology and Laboratory Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA., Harrell M; The Memorial Center for Integrative Endocrine Surgery, Hollywood, Weston and Boca Raton, Florida, USA., Patel KN; Division of Endocrine Surgery, Department of Surgery, NYU Langone Medical Center, New York, New York, USA., Shanik MH; Endocrine Associates of Long Island, Smithtown, New York, USA., Traweek ST; Thyroid Cytopathology Partners, Austin, Texas, USA., Walsh PS; Department of Research and Development, Veracyte, Inc., South San Francisco, California, USA., Yeh MW; Section of Endocrine Surgery, UCLA David Geffen School of Medicine, Los Angeles, California, USA., Abdelhamid Ahmed AH; Division of Thyroid and Parathyroid Endocrine Surgery, Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, USA., Ho AS; Department of Otolaryngology, Cedars-Sinai Medical Center, Los Angeles, California, USA., Wong RJ; Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Klopper JP; Department of Medical Affairs, Veracyte, Inc., South San Francisco, California, USA., Huang J; Department of Research and Development, Veracyte, Inc., South San Francisco, California, USA., Kennedy GC; Department of Research and Development, Veracyte, Inc., South San Francisco, California, USA.; Department of Medical Affairs, Veracyte, Inc., South San Francisco, California, USA., Kloos RT; Department of Medical Affairs, Veracyte, Inc., South San Francisco, California, USA., Sadow PM; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Massachusetts Eye and Ear, Boston, Massachusetts, USA.

Publikováno v: Thyroid : official journal of the American Thyroid Association [Thyroid] 2022 Sep; Vol. 32 (9), pp. 1069-1076. Date of Electronic Publication: 2022 Aug 08.

Efficacy and safety of MYL-1501D versus insulin glargine in people with type 1 diabetes mellitus: Results of the INSTRIDE 3 phase 3 switch study.

Autor: Blevins TC; Texas Diabetes and Endocrinology, Austin, Texas, United States., Barve A; Mylan Inc, Canonsburg, Pennsylvania, United States., Raiter Y; Mylan EPD, Amstelveen, The Netherlands., Aubonnet P; Mylan EPD, Steinhausen, Switzerland., Athalye S; Biocon Research Limited, Bangalore, India., Sun B; Mylan Inc, Canonsburg, Pennsylvania, United States., Muniz R; Mylan Inc, Canonsburg, Pennsylvania, United States.

Publikováno v: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2020 Mar; Vol. 22 (3), pp. 365-372. Date of Electronic Publication: 2019 Dec 04.

Efficacy and safety of MYL-1501D versus insulin glargine in patients with type 2 diabetes after 24 weeks: Results of the phase III INSTRIDE 2 study.

Autor: Blevins TC; Texas Diabetes and Endocrinology, Austin, Texas., Barve A; Mylan Inc, Canonsburg, Pennsylvania., Sun B; Mylan Inc, Canonsburg, Pennsylvania., Raiter Y; Mylan EPD, Amstelveen, The Netherlands., Aubonnet P; Mylan EPD, Allschwil, Switzerland., Muniz R; Mylan Inc, Canonsburg, Pennsylvania., Athalye S; Biocon Research Ltd, Bangalore, India., Ankersen M; Mylan Inc, Canonsburg, Pennsylvania.

Publikováno v: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2019 Jan; Vol. 21 (1), pp. 129-135. Date of Electronic Publication: 2018 Sep 04.